← Back to Analyst Consensus 
BFRI Buy
Biofrontera Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 19, 2026 | Benchmark | downgrade | Buy → Speculative Buy | — | 54% |
| May 19, 2025 | Benchmark | maintain | Buy → Buy | $2.75 | 54% |
| Nov 15, 2024 | Benchmark | reiterate | Buy → Buy | $7 | 54% |
| Aug 16, 2024 | Benchmark | reiterate | Buy → Buy | $7 | 54% |
| Aug 31, 2023 | Benchmark | reiterate | Buy → Buy | $18 | 54% |
Price Target Trend
Apr 25, 2026 Latest: $6 Oct 22, 2026
EPS Estimates
0y $-0.18
Lo: $-0.18 Hi: $-0.18
1 analysts 0q $-0.11
Lo: $-0.11 Hi: $-0.11
1 analysts ▲1
+1q $0.31
Lo: $0.31 Hi: $0.31
1 analysts ▲1
+1y $0.43
Lo: $0.43 Hi: $0.43
1 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days